Discontinuation of Renin-Angiotensin System Inhibitors during Acute Kidney Injury Episode and All-Cause Mortality: Target Trial Emulation Studies
- PMID: 40531580
- DOI: 10.1681/ASN.0000000775
Discontinuation of Renin-Angiotensin System Inhibitors during Acute Kidney Injury Episode and All-Cause Mortality: Target Trial Emulation Studies
Keywords: ACE inhibitors; AKI; AKI and critical care; mortality.
References
-
- Hoste EAJ, Kellum JA, Selby NM, et al. Global epidemiology and outcomes of acute kidney injury. Nat Rev Nephrol. 2018;14(10):607–625. doi: 10.1038/s41581-018-0052-0 - DOI
-
- Bangalore S, Fakheri R, Wandel S, Toklu B, Wandel J, Messerli FH. Renin angiotensin system inhibitors for patients with stable coronary artery disease without heart failure: systematic review and meta-analysis of randomized trials. BMJ. 2017;356:j4. doi: 10.1136/bmj.j4 . - DOI
-
- Evans M, Carrero JJ, Szummer K, et al. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in myocardial infarction patients with renal dysfunction. J Am Coll Cardiol. 2016;67(14):1687–1697. doi: 10.1016/j.jacc.2016.01.050 - DOI
-
- Kidney Disease Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int. 2021;99(3S):S1–S87. doi: 10.1016/j.kint.2020.11.003 - DOI
-
- Menez S, Parikh CR. Renin-angiotensin system blockade after acute kidney injury: the plot thickens. Clin J Am Soc Nephrol. 2020;15(1):2–4. doi: 10.2215/CJN.13801119 - DOI
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
